fashion -WSS

fashion

author：entertainment 2025-09-27 12:47:56 - browse：91489

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Hilary expected to bring catastrophic, life

Wikipedia

hotspot

WSS

As Maui death toll rises, number of missing remains unclear

Alabama IVF ruling threatens families facing fatal genetic disease

As Maui death toll rises, number of missing remains unclear

Patient advocates sound warning on FDA proposal on salt intake

As Maui death toll rises, number of missing remains unclear

Living with Hashimoto's and celiac disease, and med school, too

explore

fashion

focus

Wildfire smoke exposes gaps in outdoor worker protections

Living with Hashimoto's and celiac disease, and med school, too

Continuity nursing helped my family in our darkest PICU moments

A solution to the after

New air purifier tech could be key to improving indoor air quality

Living with Hashimoto's and celiac disease, and med school, too

Hollywood unions extend contract negotiations for actors

Obesity drugs seen as possible treatment for liver disease MASH

The high cost of giving birth even with insurance

New documents shed light on MD Anderson Cancer Institute feud

knowledge

Living with Hashimoto's and celiac disease, and med school, too

New details revealed about Purdue's marketing of OxyContin

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Why palliative psychiatry is worth discussing

NIH study of ME/CFS points to clear biological hallmarks

Eye stem cell transplant could help restore vision in injured people

Wikipedia

hotspot

entertainment

knowledge